Giant Biogene Holding Balance Sheet Health
Financial Health criteria checks 6/6
Giant Biogene Holding has a total shareholder equity of CN¥6.0B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥7.8B and CN¥1.8B respectively. Giant Biogene Holding's EBIT is CN¥2.0B making its interest coverage ratio -31.7. It has cash and short-term investments of CN¥6.1B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -31.7x |
| Cash | CN¥6.06b |
| Equity | CN¥5.97b |
| Total liabilities | CN¥1.81b |
| Total assets | CN¥7.78b |
Recent financial health updates
No updates
Recent updates
Revenue Beat: Giant Biogene Holding Co., Ltd. Beat Analyst Estimates By 12%
Aug 21
Does Giant Biogene Holding (HKG:2367) Deserve A Spot On Your Watchlist?
Aug 09Giant Biogene Holding Co., Ltd.'s (HKG:2367) Popularity With Investors Is Clear
Jul 01Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?
Apr 17Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings
Mar 28Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 27Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?
Dec 24A Look At The Intrinsic Value Of Giant Biogene Holding Co., Ltd. (HKG:2367)
Oct 30Giant Biogene Holding Co., Ltd.'s (HKG:2367) Share Price Matching Investor Opinion
Mar 28Financial Position Analysis
Short Term Liabilities: 2367's short term assets (CN¥6.7B) exceed its short term liabilities (CN¥1.8B).
Long Term Liabilities: 2367's short term assets (CN¥6.7B) exceed its long term liabilities (CN¥50.1M).
Debt to Equity History and Analysis
Debt Level: 2367 is debt free.
Reducing Debt: 2367 has not had any debt for past 5 years.
Debt Coverage: 2367 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 2367 has no debt, therefore coverage of interest payments is not a concern.